Eastman Chemical Company filings document regulatory disclosures for a global specialty materials issuer with publicly traded common stock and outstanding debt securities. Form 8-K reports furnish quarterly and annual operating results, including sales, EBIT, cash flow, segment performance, price-cost conditions, raw-material pressures and updates tied to specialty businesses and methanolysis assets.
Proxy materials describe director elections, board committee matters, executive compensation, say-on-pay voting and shareholder proposals. Other material-event filings record debt issuance under registration statements and indentures, officer and director changes, compensatory arrangements, common stock references and note terms, including interest, maturity and redemption provisions.
Eastman Chemical Company reported that on November 3, 2025 it publicly released its financial results for third quarter 2025. The company made these results available through a press release that is furnished as Exhibit 99.01 to its current report. The information in the press release is treated as furnished, not filed, under the Securities Exchange Act of 1934 and is only incorporated into other securities filings if specifically referenced. The report is signed on behalf of Eastman Chemical Company by Michelle R. Stewart, Vice President, Chief Accounting Officer and Corporate Controller.
Damon J. Audia, a director of Eastman Chemical Co. (EMN), reported crediting of 1,360 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan. The report shows two entries: 873 units credited at a market-linked value of $62.35 each and 487 units credited with a $0 price (automatic deferral), totaling 1,360 units beneficially owned following the transactions. These phantom units mirror the market value of one share each but are payable only in cash after the director's service ends, and thus do not represent actual shares with voting rights.
The Form 4 was filed as a single reporting person filing and signed by power of attorney on 10/09/2025. The entries reflect voluntary and automatic deferrals of director retainer fees into the director's deferred stock account rather than open-market purchases or option exercises.
Eastman Chemical (EMN) director Renee J. Hornbaker reported an automatic deferral under the Directors' Deferred Compensation Plan. On 10/07/2025, she was credited with 487 phantom stock units (value equal to one share of common stock), at a price of $0, reflecting a portion of her annual retainer fees. Phantom units are payable only in cash after service as a director ends.
Following the transaction, she beneficially owned 49,781 derivative securities. This total includes 1,151 units credited since April 7, 2025 as hypothetical reinvestment of dividend equivalents.
Eastman Chemical (EMN) director Linnie M. Haynesworth reported acquiring 487 Phantom Stock Units on 10/07/2025 at $0, reflecting an automatic deferral of a portion of her annual director retainer into the Directors' Deferred Compensation Plan. After the transaction, she beneficially owns 3,559 phantom units. Each unit has a value equal to one share of common stock and is payable only in cash after her service as a director ends. The total includes 42 units credited since May 1, 2025 as hypothetical reinvestment of dividend equivalents.
Director Eric L. Butler received 487 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan; each unit tracks one share of common stock and is payable in cash only after he leaves board service. Those units were credited via an automatic deferral of part of his annual retainer and include 53 units credited since 04/07/2025 as hypothetical reinvestment of dividend equivalents. After this transaction, Mr. Butler beneficially owns 2,768 shares (direct). The reported price per unit/share for the transaction is $0, reflecting an internal accounting credit rather than an open-market purchase. The filing was signed by a power of attorney on behalf of Mr. Butler on 10/09/2025.
Insider filing for Eastman Chemical Co. (EMN) reports that director Julie Fasone received 487 phantom stock units under the Directors' Deferred Compensation Plan on 10/07/2025. These units mirror the market value of one share each and are payable only in cash after she leaves board service. The filing shows 14,377 common-stock-equivalent units beneficially owned after the transaction, which includes 324 units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units represent an automatic deferral of part of her annual retainer that would otherwise have been paid in cash. The filing was signed by a power of attorney on 10/09/2025.
James J. O'Brien, a director of Eastman Chemical Co. (EMN), acquired 487 phantom stock units under the company's Directors' Deferred Compensation Plan on 10/07/2025. These units are valued like common shares but are payable only in cash after he leaves board service. The report shows 17,407 shares (or equivalent units) beneficially owned following the transaction, which includes 395 additional units credited since 04/07/2025 from reinvested dividend equivalents. The 487 units arose from an automatic deferral of part of his annual retainer that would otherwise have been paid in cash; the per‑unit price for the phantom units is reported as $0 for administrative reporting purposes.
Eastman Chemical (EMN) director transaction: On 10/07/2025, a director acquired 487 phantom stock units under the Directors' Deferred Compensation Plan, recorded at $0 as an automatic deferral of a portion of annual retainer fees. Following this, the director beneficially owned 1,267 phantom stock units. These units track the value of common stock and are payable only in cash after the director’s service ends. The total includes 19 units credited since April 7, 2025 from dividend-equivalent reinvestments.
Brett D. Begemann, a director of Eastman Chemical Co. (EMN), received a total of 1,827 phantom stock units on 10/07/2025 under the Directors' Deferred Compensation Plan. These units represent cash‑payable credits tied to the issuer's common stock and were recorded as voluntary and automatic deferrals of director retainer fees; 1,340 units were a voluntary deferral and 487 units an automatic deferral. The filing shows 55,811 common‑share equivalents beneficially owned after the transaction, which includes 1,178 units from reinvested dividend equivalents credited since 05/01/2025. The units have no exercise price and are payable only in cash after termination of director service.
Insider transaction summary: A director of Eastman Chemical Co. (EMN) recorded a non‑cash acquisition of 487 phantom stock units on 10/07/2025. The units were credited under the Directors' Deferred Compensation Plan as an automatic deferral of a portion of annual retainer fees that would otherwise have been paid in cash. Phantom units track the market value of one share and are payable in cash after the director's service ends. Following the transaction the reporting person beneficially owns 13,391 common‑stock‑equivalent units, which includes 268 units credited since 05/01/2025 for reinvested dividend equivalents.